コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 abetes mellitus is the major risk factor for cardiovascular disorders.
2 se potentially lethal, yet highly treatable, cardiovascular disorders.
3 been observed in sporadic neurocognitive and cardiovascular disorders.
4 maceuticals for the treatment of cancers and cardiovascular disorders.
5 rious pathological states such as cancer and cardiovascular disorders.
6 s to the pathogenesis of certain cancers and cardiovascular disorders.
7 ts, as well as diagnostics, for a variety of cardiovascular disorders.
8 invaluable resource for the study of certain cardiovascular disorders.
9 th cumulative drug exposures and preexisting cardiovascular disorders.
10 ecting the impact of chronic inflammation in cardiovascular disorders.
11 tates, such as pulmonary, hematological, and cardiovascular disorders.
12 target for the treatment of hypertension and cardiovascular disorders.
13 esistance and other features of T2DM such as cardiovascular disorders.
14 findings could have implications in various cardiovascular disorders.
15 ting effects in some autoimmune diseases and cardiovascular disorders.
16 increased morbidity and mortality in various cardiovascular disorders.
17 tabolic, oncological, neurodegenerative, and cardiovascular disorders.
18 in the treatment of hypertension and related cardiovascular disorders.
19 ective PDE5A inhibition for the treatment of cardiovascular disorders.
20 lasma protein that has beneficial actions on cardiovascular disorders.
21 ophy, and diastolic dysfunction, among other cardiovascular disorders.
22 nd inflammation may improve the treatment of cardiovascular disorders.
23 get for therapeutic intervention in ischemic cardiovascular disorders.
24 conditions have increased susceptibility to cardiovascular disorders.
25 present a novel mechanism in LVH and related cardiovascular disorders.
26 to influence the occurrence of a variety of cardiovascular disorders.
27 coarctation or recoarctation and concomitant cardiovascular disorders.
28 tion are early events in angiotensin-induced cardiovascular disorders.
29 ing mechanisms leading to the onset of acute cardiovascular disorders.
30 identify the genetic abnormalities in other cardiovascular disorders.
31 reduced overall mortality and mortality from cardiovascular disorders.
32 erated by the heart to identify and diagnose cardiovascular disorders.
33 adiponectin and leptin in obesity-associated cardiovascular disorders.
34 cy, and subsequent diagnosis of 12 different cardiovascular disorders.
35 nge of lifestyle diseases, particularly with cardiovascular disorders.
36 rally over many decades for the treatment of cardiovascular disorders.
37 ocesses underlying cancer, inflammation, and cardiovascular disorders.
38 eptin ratio as a means to prevent or reverse cardiovascular disorders.
39 iponectin is emerging in the pathogenesis of cardiovascular disorders.
40 ality and the disease risk of several common cardiovascular disorders.
41 ating peripheral artery disease and ischemic cardiovascular disorders.
42 ng the role of precision medicine applied to cardiovascular disorders.
43 ty and ageing in the pathogenesis of various cardiovascular disorders.
44 successful record in the clinic for treating cardiovascular disorders.
45 c diseases, including obesity, diabetes, and cardiovascular disorders.
46 ging and diseases like neurodegeneration and cardiovascular disorders.
47 ribute to predictive models for glaucoma and cardiovascular disorders.
48 a major role in the pathogenesis of multiple cardiovascular disorders.
49 arget diseases such as diabetes, cancer, and cardiovascular disorders.
50 tility in the metabolic syndrome and related cardiovascular disorders.
51 during aging, neurocognitive, metabolic, and cardiovascular disorders.
52 ety of age-associated pathologies, including cardiovascular disorders.
53 ing retinopathy, nephropathy, neuropathy and cardiovascular disorders.
54 for heart disease, and those with prevalent cardiovascular disorders.
55 attractive drug targets for treating several cardiovascular disorders.
56 receptor (A2AR) has long been implicated in cardiovascular disorders.
57 yopathy, one of the most prevalent heritable cardiovascular disorders.
58 effective in the prevention and treatment of cardiovascular disorders.
59 the contributions of the expressed genome to cardiovascular disorders.
60 cation channel associated with a variety of cardiovascular disorders.
61 otease of post-translational SUMOylation, in cardiovascular disorders.
62 connection between autophagy, mitophagy, and cardiovascular disorders.
63 sing therapeutic and biomarker candidate for cardiovascular disorders.
64 nd is strongly associated with metabolic and cardiovascular disorders.
65 tagonist drugs are widely used in therapy of cardiovascular disorders.
66 ng diseases, such as cancer angiogenesis and cardiovascular disorders.
67 is closely related to various metabolic and cardiovascular disorders.
68 al window for intervention to prevent future cardiovascular disorders.
69 es, such as cancers, osteoporosis, lung, and cardiovascular disorders.
70 inhibitor is commonly used in patients with cardiovascular disorders.
71 lled trials of treatment duration in various cardiovascular disorders.
72 diseases, diabetes, infectious diseases, and cardiovascular disorders.
73 s HIV and Hantavirus infection, diabetes and cardiovascular disorders.
74 of age-related diseases, including multiple cardiovascular disorders.
75 ed with endothelial dysfunction in different cardiovascular disorders.
76 enes associated with psychiatric, immune and cardiovascular disorders.
77 atoid arthritis, and multiple sclerosis) and cardiovascular disorders.
78 ave a higher risk of other diseases, such as cardiovascular disorders.
79 occurrence of various pathologies including cardiovascular disorders.
80 c targets to treat dyslipidemias and related cardiovascular disorders.
81 s a disease-modifying therapeutic target for cardiovascular disorders.
82 w that LNK is associated with autoimmune and cardiovascular disorders.
83 eatly influences the pathogenesis of various cardiovascular disorders.
84 othyroidism as an epigenetic risk factor for cardiovascular disorders.
85 ponectin and leptin and its association with cardiovascular disorders, (2) further discuss the underl
87 ve incidence of a composite end point of any cardiovascular disorder according to preeclampsia exposu
90 e in obesity, which worsens the incidence of cardiovascular disorders and cancer, the 2 leading cause
92 opmental abnormalities and diseases, such as cardiovascular disorders and cancer; however, the stimul
94 ilar pattern of increased risk across all 12 cardiovascular disorders and chronic hypertension, and t
98 erstanding of pathogenesis of several common cardiovascular disorders and may lead to the development
99 for correcting genetic causes of hereditary cardiovascular disorders and modulating pathogenic signa
100 overlapping associations with autoimmune and cardiovascular disorders and other circulating biomarker
101 nflammation is associated with metabolic and cardiovascular disorders and PVN AT1a deletion reduced i
102 al anomalies and respiratory, endocrine, and cardiovascular disorders and was not associated with mor
103 d the pathophysiology of several inheritable cardiovascular disorders and will ultimately change the
104 icoagulant therapies, prevent and treat many cardiovascular disorders and, as such, are some of the m
105 tative solid tumor, and thrombosis, a common cardiovascular disorder, and demonstrate urinary detecti
106 d are the targets of drugs designed to treat cardiovascular disorders, and ACE inhibitors are commonl
108 G) is associated with systemic metabolic and cardiovascular disorders, and both share common risk fac
113 th disease symptoms such as peptic ulcers or cardiovascular disorders, and epidemiological studies st
114 ase, psychiatric disorders, renal disorders, cardiovascular disorders, and liver disease in Europe; h
116 bolic diseases such as obesity and diabetes, cardiovascular disorders, and neurological and cognitive
117 ernal death during delivery hospitalization, cardiovascular disorders, and obstetric hemorrhage.
118 h as mitochondrial neuropathies, myopathies, cardiovascular disorders, and Parkinson and Alzheimer di
119 ediated inflammatory diseases, metabolic and cardiovascular disorders, and psychiatric comorbidities.
120 ange of systemic diseases, such as diabetes, cardiovascular disorders, and rheumatological conditions
121 (miR-122) is associated with the severity of cardiovascular disorders, and targeting it with efficien
122 applications in the context of a variety of cardiovascular disorders, and their respective merits, l
123 s in each of the subcategories of congenital cardiovascular disorders, and will provide the reader wi
125 such as nonalcoholic fatty liver disease and cardiovascular disorders are known to have a major infla
129 -3 fatty acids may be effective in epilepsy, cardiovascular disorders, arthritis, and as mood stabili
130 and treatment of subclinical or progressive cardiovascular disorders, as in acute coronary syndrome,
132 Pulmonary arterial hypertension (PAH) is a cardiovascular disorder associated with enhanced prolife
133 is (DVT) and pulmonary embolism, is a common cardiovascular disorder associated with significant morb
134 alue in human psychiatric, reproductive, and cardiovascular disorders associated with CRH system hype
136 be a promising strategy to lower the risk of cardiovascular disorders associated with obesity and typ
137 te to the known beneficial effects of BH4 in cardiovascular disorders associated with oxidative stres
138 re targets to develop clinical therapies for cardiovascular disorders associated with oxidative stres
139 ies for deploying gene editing therapies for cardiovascular disorders augur well for the future of th
140 urodegenerative diseases, diabetes, obesity, cardiovascular disorders, autoimmune diseases, inflammat
141 stinal disorders, sarcopenia and osteopenia, cardiovascular disorders, bacterial overgrowth, and nutr
142 as been implicated in asthma, autoimmune and cardiovascular disorders, but its role in other respirat
144 I) is a well-established participant in many cardiovascular disorders, but the mechanisms involved ar
145 lmarks of endothelial dysfunction leading to cardiovascular disorders, but the underlying molecular m
146 em (RAS) plays pathogenic roles in renal and cardiovascular disorders, but whether it is involved in
147 se and 1749 control participants free of any cardiovascular disorders by use of a validated ex-vivo r
148 of diabetic complications, and perhaps other cardiovascular disorders, by attenuating oxidative/nitra
151 arterial hypertension (PAH) is a devastating cardiovascular disorder characterized by the remodelling
153 and prognostic value across the spectrum of cardiovascular disorders compared with ejection fraction
154 was utilized to compare mortality rates for cardiovascular disorder (CVD), coronary heart disease (C
156 Portal vein thrombosis (PVT) and different cardiovascular disorders (CVDs) were the indication for
158 or syncope captured genetic correlation with cardiovascular disorders, diabetes, depression, and shor
159 r a range of conditions, including epilepsy, cardiovascular disorders, drug-resistant depression, chr
160 been hypothesized to play a role in various cardiovascular disorders for over two decades, our resul
161 ental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, ma
162 the interest in ACE as a candidate gene for cardiovascular disorders, has led to extensive investiga
164 pregnancy hypertensive disorders and common cardiovascular disorders have not been investigated at s
165 duals without evident heart failure or other cardiovascular disorders, higher CRP was associated with
166 oding LNK are associated with autoimmune and cardiovascular disorders; however, it is not known how L
167 vasodilators are used to treat a variety of cardiovascular disorders; however, the signal transducti
168 placebo group and a pre-existing unspecified cardiovascular disorder in the abobotulinumtoxinA 500 U
169 eeclampsia alone (term and preterm), with 12 cardiovascular disorders in addition to chronic hyperten
170 ciated with an increased risk of adult-onset cardiovascular disorders in children born to mothers wit
175 ed with obesity, the metabolic syndrome, and cardiovascular disorders in observational and short-term
176 ecular basis for the observed higher risk of cardiovascular disorders in PTSD patients, which raises
177 ng ion channels or ion channel modulators in cardiovascular disorders including cardiac arrhythmia su
179 risk for the development and progression of cardiovascular disorders including hypertension, dyslipi
180 least studied complications of NF1 involves cardiovascular disorders, including arterial occlusions
181 othelium dysfunction is a principal event in cardiovascular disorders, including atherosclerosis.
182 apeutic targets for the treatment of several cardiovascular disorders, including cardiac arrhythmia a
183 ol consumption has long been associated with cardiovascular disorders, including cardiomyopathy, hype
184 e (cGMP) signaling has been observed in many cardiovascular disorders, including heart failure and pu
185 the treatment of epilepsy, chronic pain, and cardiovascular disorders, including hypertension, angina
187 reported to be at increased risk for various cardiovascular disorders, including left ventricular hyp
190 for cholesterol control among patients with cardiovascular disorders (increasing from 14 percent to
191 on that occurs in diverse conditions such as cardiovascular disorders, inflammatory diseases, and neo
192 nditions, correct differentiation from other cardiovascular disorders is important, because therapy o
195 tabolic syndrome, a cluster of metabolic and cardiovascular disorders, is systemic insulin resistance
197 osis of several health conditions, including cardiovascular disorders, joint quality, and Alzheimer's
198 reparticipation examination is to detect the cardiovascular disorders known to cause sudden cardiac a
200 of sex steroid hormones on the incidence of cardiovascular disorders, little is known about the neur
201 hanges in prescribing oral beta-blockers for cardiovascular disorders may affect the number of those
202 ifying risk factors for developing new-onset cardiovascular disorders may draw clinical attention for
203 therapeutic targets for pathologies such as cardiovascular disorders, neurodegenerative diseases, an
204 ischemic and nonischemic cerebrovascular and cardiovascular disorders, neurological disorders, rheuma
205 gastrointestinal disorders (14 admissions), cardiovascular disorders (nine), sepsis syndrome (six),
207 ous types of imaging of the diseases such as cardiovascular disorders, obesity, and cancer where macr
208 nt to human health, including cancer, aging, cardiovascular disorders, obesity, infectious disease su
209 heral arterial disease (PAD) is an important cardiovascular disorder of the peripheral arteries.
211 neuromuscular disorders, hemophilia, primary cardiovascular disorders, or disorders with cardiovascul
212 rts to eradicate HIV, treat neurological and cardiovascular disorders, or enhance antigen density in
213 from the realization that several hereditary cardiovascular disorders originate from gene mutations t
214 ill potentially enhance our understanding of cardiovascular disorders, particularly in patients whose
215 trophic cardiomyopathy (HCM) is an inherited cardiovascular disorder primarily caused by mutations in
216 pertrophic cardiomyopathy (HCM) is a genetic cardiovascular disorder, primarily involving mutations i
218 cytes generated from patients with inherited cardiovascular disorders recapitulate key phenotypic fea
219 low-up for timely detection and treatment of cardiovascular disorders related to the development of A
220 used as a Chinese medicine for patients with cardiovascular disorders, selectively abrogated endotoxi
222 ty and mortality advantage for patients with cardiovascular disorders, similar benefits might also ac
224 osclerosis, which underlies life-threatening cardiovascular disorders such as myocardial infarction a
225 r proportion of patients with NAFLD die from cardiovascular disorders than patients with ALD, whereas
226 Peripheral artery disease (PAD) is a common cardiovascular disorder that is frequently underdiagnose
227 pidemiological studies to a wide spectrum of cardiovascular disorders that are characterized by a dys
230 with advanced age and contributes to making cardiovascular disorders the leading cause of death of e
231 a critical pathway and therapeutic target in cardiovascular disorders, the involvement of this ectonu
232 nts with sepsis, rhabdomyolysis, cancer, and cardiovascular disorders, the underlying disease or asso
233 he early diagnosis of cancer, infection, and cardiovascular disorders through photoacoustic detection
234 dly diseases such as cancer, infections, and cardiovascular disorders through the detection of rare c
236 tudy investigated the incidence of new-onset cardiovascular disorders up to 3.5 years post SARS-CoV-2
237 decades to aid our understanding of complex cardiovascular disorders using a reductionist approach.
238 The incidence and mortality of the major cardiovascular disorders vary sharply by occupation, but
240 ng the 20-year study period, 18 624 incident cardiovascular disorders were observed, 65% of which had
241 regnancy-associated death (n = 50; 20%), and cardiovascular disorders were the second-leading cause (
242 cholesterol carries a risk for metabolic and cardiovascular disorders, whereas high-density lipoprote
243 he comorbidities of HS include metabolic and cardiovascular disorders, which contribute to reduced li
244 iPSC-derived cardiomyocytes to study genetic cardiovascular disorders will enable a deeper and more a
245 on fraction (HFpEF) is a joint metabolic and cardiovascular disorder with significant noncardiac cont
246 Periodontal disease has been associated with cardiovascular disorders with an atherosclerotic backgro
247 Orthostatic hypotension (OH) is a common cardiovascular disorder, with or without signs of underl
248 omyopathy (HCM) is the most common inherited cardiovascular disorder, yet the genetic cause of up to